title: 5-HT1A receptor activation reduces fear-related behavior following social defeat in Syrian hamsters.
abstract: Social defeat leads to selective avoidance of familiar opponents as well as general avoidance of novel, non-threatening intruders. Avoidance of familiar opponents represents a fear-related memory whereas generalized social avoidance indicates anxiety-like behavior. We have previously shown that serotonin signaling alters responses to social defeat in Syrian hamsters, although it is unclear whether serotonin modulates defeat-induced fear, anxiety, or both. In this study we focus on 5-HT1A receptors, in part, because their activation had been linked to the acquisition of conditioned fear. We hypothesized that pharmacological activation of 5-HT1A receptors prior to social defeat would reduce avoidance of familiar opponents and impair Arc expression in the basolateral amygdala (BLA), but not alter anxiety-like behavior. We administered 8-OH-DPAT, a 5-HT1A receptor agonist, prior to 3, 5-minute social defeats and 24h later exposed hamsters to a social interaction test to measure the conditioned defeat response immediately followed by either a Y-maze test or an open field test. In a separate experiment, we administered 8-OH-DPAT prior to 3, 5-minute social defeats and later removed the brains for Arc immunohistochemistry. Social defeat increased the number of Arc immunopositive cells in the central amygdala (CeA), prelimbic cortex (PL), and BLA, and 8-OH-DPAT treatment reduced Arc immunoreactivity in the PL. These results suggest that 5-HT1A receptor activation impairs the fear memory associated with social defeat, but does not alter defeat-induced anxiety. Overall, 5-HT1A receptor activation may impair Arc expression in select brain regions such as the PL and thereby disrupt the development of a fear memory essential for the conditioned defeat response.
authors.affiliation: Department of Psychology, University of Tennessee, Knoxville, TN 37996, USA. Electronic address: lbader@utk.edu.
authors.forename: Lauren R
authors.initials: LR
authors.lastname: Bader
authors.affiliation: Department of Psychology, University of Tennessee, Knoxville, TN 37996, USA.
authors.forename: Joseph D
authors.initials: JD
authors.lastname: Carboni
authors.affiliation: Department of Psychology, University of Tennessee, Knoxville, TN 37996, USA.
authors.forename: Cody A
authors.initials: CA
authors.lastname: Burleson
authors.affiliation: Department of Psychology, University of Tennessee, Knoxville, TN 37996, USA.
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Cooper
mesh_terms: D000818:Animals; D001007:Anxiety / Q000378:metabolism / Q000517:prevention & control / Q000523:psychology; D006224:Cricetinae; D005239:Fear / Q000187:drug effects / Q000502:physiology* / Q000523:psychology; D008297:Male; D008647:Mesocricetus; D044282:Receptor, Serotonin, 5-HT1A / Q000378:metabolism*; D058825:Serotonin 5-HT1 Receptor Agonists / Q000494:pharmacology / Q000627:therapeutic use; D012919:Social Behavior; D013315:Stress, Psychological / Q000378:metabolism* / Q000517:prevention & control / Q000523:psychology
chemical_list: D058825:Serotonin 5-HT1 Receptor Agonists; D044282:Receptor, Serotonin, 5-HT1A
keywords: 5-HT1A receptor; Anxiety; Conditioned defeat; Fear; Serotonin; Social defeat
references.citation: Behav Processes. 2011 Jan;86(1):94-101
references.pmid: 20974232
references.citation: Learn Mem. 2006 Nov-Dec;13(6):728-33
references.pmid: 17142302
references.citation: Eur J Pharmacol. 2008 Oct 31;596(1-3):107-10
references.pmid: 18789922
references.citation: Psychoneuroendocrinology. 2004 Aug;29(7):899-910
references.pmid: 15177705
references.citation: Biochem Biophys Res Commun. 2012 May 4;421(2):301-4
references.pmid: 22503976
references.citation: J Neurosci. 2005 Dec 7;25(49):11239-47
references.pmid: 16339019
references.citation: Horm Behav. 2003 Sep;44(3):293-9
references.pmid: 14609551
references.citation: Neuroscientist. 2005 Aug;11(4):323-33
references.pmid: 16061519
references.citation: Front Behav Neurosci. 2011 Nov 02;5:72
references.pmid: 22065953
references.citation: J Neurosci. 2007 Sep 26;27(39):10445-55
references.pmid: 17898216
references.citation: J Endocrinol. 1999 Jan;160(1):1-12
references.pmid: 9854171
references.citation: Behav Neurosci. 2005 Aug;119(4):1125-30
references.pmid: 16187840
references.citation: Behav Brain Res. 2005 Jul 1;162(1):127-34
references.pmid: 15922073
references.citation: Nat Neurosci. 2005 Mar;8(3):365-71
references.pmid: 15696163
references.citation: Am J Psychiatry. 2001 Aug;158(8):1326-8
references.pmid: 11481173
references.citation: Brain Res Mol Brain Res. 2004 Oct 22;129(1-2):104-16
references.pmid: 15469887
references.citation: Biol Psychiatry. 2000 Dec 15;48(12):1157-63
references.pmid: 11137057
references.citation: Stress. 1996 Jul;1(1):21-32
references.pmid: 9807059
references.citation: J Neurosci Res. 2011 May;89(5):773-90
references.pmid: 21337371
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14476-81
references.pmid: 9826725
references.citation: Behav Neurosci. 2010 Aug;124(4):455-69
references.pmid: 20695645
references.citation: Physiol Behav. 2012 Jan 18;105(2):493-7
references.pmid: 21945371
references.citation: Physiol Behav. 2003 Aug;79(3):417-27
references.pmid: 12954436
references.citation: Physiol Behav. 1993 May;53(5):983-93
references.pmid: 8511216
references.citation: Horm Behav. 2009 Jan;55(1):158-62
references.pmid: 18948107
references.citation: Pharmacol Biochem Behav. 2012 Jan;100(3):592-600
references.pmid: 21967885
references.citation: Physiol Behav. 2002 Jun 1;76(2):225-39
references.pmid: 12044595
references.citation: Eur J Pharmacol. 2004 Mar 8;487(1-3):125-32
references.pmid: 15033384
references.citation: J Neurosci. 2011 Oct 5;31(40):14107-15
references.pmid: 21976495
references.citation: Brain Res. 1992 May 29;581(2):190-7
references.pmid: 1327398
references.citation: Horm Behav. 2007 Aug;52(2):211-9
references.pmid: 17555756
references.citation: J Neurosci. 2000 Nov 15;20(22):8515-27
references.pmid: 11069959
references.citation: Physiol Behav. 1996 Jul;60(1):115-9
references.pmid: 8804650
references.citation: Pharmacol Biochem Behav. 2006 Sep;85(1):1-11
references.pmid: 16914188
references.citation: Psychoneuroendocrinology. 2008 Oct;33(9):1236-47
references.pmid: 18692968
references.citation: J Neurosci. 2001 Sep 1;21(17):6889-96
references.pmid: 11517276
references.citation: Behav Brain Res. 2011 Feb 2;217(1):55-9
references.pmid: 20933543
references.citation: Neuroscience. 1998 Jan;82(1):147-59
references.pmid: 9483511
references.citation: Physiol Behav. 1996 Apr-May;59(4-5):735-9
references.pmid: 8778860
references.citation: Behav Neurosci. 2011 Dec;125(6):911-20
references.pmid: 22122152
references.citation: Behav Brain Res. 2011 Mar 17;218(1):8-14
references.pmid: 21094664
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2675-80
references.pmid: 20133801
references.citation: Psychopharmacology (Berl). 2004 Dec;177(1-2):46-54
references.pmid: 15167982
references.citation: Br J Psychiatry Suppl. 1992 Feb;(15):36-43
references.pmid: 1356356
references.citation: Physiol Behav. 2004 Jun;81(4):629-38
references.pmid: 15178156
references.citation: J Neurosci. 1992 Feb;12(2):440-53
references.pmid: 1531498
references.citation: J Neurosci. 2011 May 11;31(19):7073-82
references.pmid: 21562269
references.citation: Behav Neural Biol. 1993 Sep;60(2):93-102
references.pmid: 8117243
references.citation: Eur Neuropsychopharmacol. 2009 Mar;19(3):215-28
references.pmid: 19147333
references.citation: Psychoneuroendocrinology. 1999 Apr;24(3):285-300
references.pmid: 10101734
references.citation: Physiol Behav. 1986;36(2):223-8
references.pmid: 3960994
references.citation: J Neurosci. 2008 Nov 19;28(47):12383-95
references.pmid: 19020031
references.citation: Psychoneuroendocrinology. 1995;20(2):117-34
references.pmid: 7899533
references.citation: Nat Neurosci. 2010 Oct;13(10):1161-9
references.pmid: 20877280
references.citation: Neuroscience. 2011 Jun 2;183:81-9
references.pmid: 21453756
references.citation: Brain Behav Immun. 2007 May;21(4):458-66
references.pmid: 17178210
references.citation: Psychopharmacol Bull. 2003 Spring;37 Suppl 1:76-88
references.pmid: 14566203
references.citation: Behav Neurosci. 2009 Jun;123(3):564-76
references.pmid: 19485563
references.citation: Neuropharmacology. 2012 Jan;62(1):474-84
references.pmid: 21925519